======= KCTD10 =======
== Gene Information ==
* **Official Symbol**: KCTD10
* **Official Name**: potassium channel tetramerization domain containing 10
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=83892|83892]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9H3F6|Q9H3F6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=KCTD10&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KCTD10|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/613421|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex. The BCR(BACURD3) E3 ubiquitin ligase complex mediates the ubiquitination of target proteins, leading to their degradation by the proteasome (By similarity). {ECO:0000250|UniProtKB:Q8WZ19}.
|K tetra|
|GTP-Rho binding|
|negative regulation of Rho protein signal transduction|
|Notch binding|
|Cul3-RING ubiquitin ligase complex|
|negative regulation of Ras protein signal transduction|
|negative regulation of small GTPase mediated signal transduction|
|regulation of Rho protein signal transduction|
|regulation of Ras protein signal transduction|
|ubiquitin-protein transferase activity|
|proteasome-mediated ubiquitin-dependent protein catabolic process|
|protein homooligomerization|
|regulation of small GTPase mediated signal transduction|
|proteasomal protein catabolic process|
|negative regulation of intracellular signal transduction|
|protein complex oligomerization|
|ubiquitin-dependent protein catabolic process|
|modification-dependent protein catabolic process|
|modification-dependent macromolecule catabolic process|
|proteolysis involved in cellular protein catabolic process|
|cellular protein catabolic process|
|protein catabolic process|
|protein ubiquitination|
|protein modification by small protein conjugation|
|cellular macromolecule catabolic process|
|protein modification by small protein conjugation or removal|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|negative regulation of signal transduction|
|proteolysis|
|negative regulation of cell communication|
|negative regulation of signaling|
|protein-containing complex assembly|
|negative regulation of response to stimulus|
|organic substance catabolic process|
|cellular catabolic process|
|regulation of intracellular signal transduction|
|protein-containing complex subunit organization|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-2.56|
|[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|-2.09|
|[[:results:exp422|Wiskostatin 3μM R07 exp422]]|-2|
|[[:results:exp474|CR131-b 0.005μM R08 exp474]]|-1.83|
|[[:results:exp295|Pyronaridine 1μM R06 exp295]]|-1.78|
|[[:results:exp189|Temozolomide 200μM R04 exp189]]|1.71|
|[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.71|
|[[:results:exp274|Citral 50μM R06 exp274]]|1.77|
|[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.83|
|[[:results:exp210|LB-100 2μM R05 exp210]]|3.33|
|[[:results:exp72|LB-100 4.1μM R02 exp72]]|7.1|
^Gene^Correlation^
|[[:human genes:p:pebp1|PEBP1]]|0.434|
Global Fraction of Cell Lines Where Essential: 57/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|2/28|
|blood|1/28|
|bone|5/26|
|breast|6/33|
|central nervous system|5/56|
|cervix|1/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|1/16|
|kidney|3/21|
|liver|2/20|
|lung|6/75|
|lymphocyte|0/16|
|ovary|2/26|
|pancreas|1/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|1/24|
|soft tissue|0/9|
|thyroid|1/2|
|upper aerodigestive|0/22|
|urinary tract|5/29|
|uterus|1/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3628
* **Expression level (log2 read counts)**: 5.86
{{:chemogenomics:nalm6 dist.png?nolink |}}